Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$541,376,786
+$63,356,820 QoQ
Shares Held
2,151,394
-2.1% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#76
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $3,769,908,119 across 17 Drug Manufacturers - General names. ABBV ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,750,788 | $2,099,947,825 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
2,151,394 | $541,376,786 | |
| 3 | JNJ |
Johnson & Johnson
|
1,943,962 | $493,708,029 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,500,619 | $192,829,541 | |
| 5 | AMGN |
Amgen Inc
|
438,431 | $158,764,633 | |
| 6 | PFE |
Pfizer Inc
|
4,509,295 | $108,583,823 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
719,424 | $90,892,028 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,140,161 | $65,696,076 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $541,376,786 | 2,151,394 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $478,019,966 | 2,197,894 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $340,717,661 | 1,491,171 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $342,461,783 | 1,479,061 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $270,054,454 | 1,454,878 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $301,808,741 | 1,440,477 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $260,897,896 | 1,468,193 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $319,760,800 | 1,619,206 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $278,218,990 | 1,622,079 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $299,835,298 | 1,646,542 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $253,730,521 | 1,637,288 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $248,549,649 | 1,667,447 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $224,541,556 | 1,666,604 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $262,876,671 | 1,649,474 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $271,672,874 | 1,681,040 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $218,807,662 | 1,630,338 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $249,291,792 | 1,627,656 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $257,256,898 | 1,586,928 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $217,142,469 | 1,603,711 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $168,252,282 | 1,559,769 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $168,309,053 | 1,494,221 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $168,219,548 | 1,554,422 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $161,126,919 | 1,503,751 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $126,769,269 | 1,447,303 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $138,133,565 | 1,406,942 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $97,064,917 | 1,273,985 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||